PYC pyc therapeutics limited

conversation with doug wilson

  1. 315 Posts.
    I was walking down Symonds St this morning (just up from the Thomas Building - Molecular Biology - UofA). Saw Doug Wilson walking the other way. So ... I introduced myself.

    What a gentleman! He was clearly on his way to another appointment - but he had time to talk PYC and NEU with a shareholder.

    He was most animated talking PYC. Ever the professional, he was guarded in giving out information. However, there were a couple of interesting "gleanings":

    i) We know about the "3 deals" likely for this year - however, I get the impression that the deal pipeline is significantly larger. As a guess, I would suggest that there are about 8 new deals in the active pipeline.

    ii) Phylogica has brought the bio-informatics unit, in-house. I get the impression that this new unit is very busy registering new compounds with the NCBI (I assume).

    (I stress, these are my "gleanings" - nothing was verified by Doug. What is certain is that this company has a chairman with intelligence and energy - bodes well for the future).
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.40
Change
-0.045(3.13%)
Mkt cap ! $813.6M
Open High Low Value Volume
$1.46 $1.46 $1.36 $314.1K 222.1K

Buyers (Bids)

No. Vol. Price($)
1 330 $1.40
 

Sellers (Offers)

Price($) Vol. No.
$1.45 12708 2
View Market Depth
Last trade - 16.10pm 14/07/2025 (20 minute delay) ?
PYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.